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Outcome of Early Initiation of Peritoneal Dialysis in Patients with 
End-Stage Renal Failure 
Recent studies reported that early initiation of hemodialysis may increase mortality. 
However, studies that assessed the influence of early initiation of peritoneal dialysis (PD) 
yielded controversial results. In the present study, we evaluated the prognosis of early 
initiation of PD on the various outcomes of end stage renal failure patients by using 
propensity-score matching methods. Incident PD patients (n = 491) who started PD at SNU 
Hospital were enrolled. The patients were divided into ‘early starters (n = 244)’ and ‘late 
starters (n = 247)’ on the basis of the estimated glomerular filtration rate (eGFR) at the 
start of dialysis. The calculated propensity-score was used for one-to-one matching. After 
propensity-score-based matching (n = 136, for each group), no significant differences 
were observed in terms of all-cause mortality (P = 0.17), technique failure (P = 0.62), 
cardiovascular event (P = 0.96) and composite event (P = 0.86) between the early and late 
starters. Stratification analysis in the propensity-score quartiles (n = 491) exhibited no 
trend toward better or poorer survival in terms of all-cause mortality. In conclusion, early 
commencement of PD does not reduce the mortality risk and other outcomes. Although 
the recent guidelines suggest that initiation of dialysis at higher eGFR, physicians should 
not determine the time to initiate PD therapy simply rely on the eGFR alone.
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INTRODUCTION
In 1997, the National Kidney Foundation workgroup recom-
mended that dialysis should be initiated when the creatinine 
(Cr) clearance falls below approximately 10.5 mL/min/1.73 m
2 
except in well-nourished, asymptomatic patients (1). In 2006, 
however, the NKF workgroup updated the guidelines for initiat-
ing dialysis at the estimated glomerular filtration rate (eGFR) 
< 15.0 mL/min/1.73 m
2. They also suggested that initiation of 
dialysis even at eGFR  > 15.0 mL/min/1.73 m
2 may be appro-
priate in patients who have symptoms related to both their co-
morbidities and their level of residual renal function (RRF) (2). 
The Canadian Society of Nephrology recommends the initia-
tion of dialysis when the eGFR is less than 12 mL/min/1.73 m
2 
and the Caring for Australians with Renal Impairment Guide-
lines specify eGFR of 10.0 mL/min/1.73 m
2 as the standard on 
which nephrologists should rely for starting dialysis therapy if 
there is evidence of uremia or its complications such as malnu-
trition (3, 4). These guidelines have influenced the clinical prac-
tice of nephrologists. According to the United States Renal Data 
System, an increase in the frequency of patients initiating dialysis 
with eGFR above 10 mL/min/1.73 m
2 is becoming evident (5). 
  Recent observational studies have not shown any benefits of 
early start of dialysis and some studies reported that early initia-
tion of dialysis may increase mortality (6-10). The Initiating Dial-
ysis Early and Late (IDEAL) study, the first randomized controlled 
trial, demonstrated that early initiation of dialysis in patients 
with chronic kidney disease stage 5 was not associated with an 
improvement in clinical outcomes (11). However, the IDEAL 
study could not address any differences between peritoneal di-
alysis (PD) or hemodialysis in terms of the association of the 
start eGFR and the subsequent outcomes, since the above study 
comprised similar proportion of PD and hemodialysis patients. 
  If dialysis modality was concerned, survival disadvantage of 
early start of dialysis would be a different story. Studies that sole-
ly assessed patients treated with hemodialysis indicated a higher Oh K-H, et al.  •  Initiation Timing of PD and Outcomes
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mortality in the early initiation group (6, 7, 12). In contrast, stud-
ies that assessed PD patients showed controversial results. Shiao 
et al. (13) demonstrated that early initiation of PD had signifi-
cant survival disadvantage. However, Tang et al. (14) showed 
increased mortality risk with decreased start eGFR at initiation 
of PD. Therefore, it is not determined whether early initiation of 
PD is beneficial or detrimental for the patient outcomes. Com-
pared with hemodialysis, PD has a beneficial effect in terms of 
preserving residual renal function (RRF) (15, 16), a major deter-
minant of various outcomes after commencing dialysis therapy 
(17, 18). Therefore, it is warranted to investigate the effect of early 
initiation of PD treatment on the patient survival and other out-
comes.
  The present study explored the benefit of the early initiation 
of PD in overall survival and other outcomes retrospectively. 
Propensity score (PS) analysis was employed to account for the 
differences of pre-dialysis factors and one-to-one matching be-
tween early and late starter groups. 
MATERIALS AND METHODS
Study subjects
We conducted the present study with retrospective data collec-
tion using PD patient database of Seoul National University 
Hospital (SNUH). All patients with chronic kidney disease are 
given unbiased information on the choice of dialysis modality 
at SNUH. The choice for dialysis modality is made at the discre-
tion of the patients themselves, although they receive medical 
advice from the nephrologists and dialysis nurses. On the aver-
age, 20 to 25% of end stage renal failure (ESRF) patients choose 
PD as their first-line dialysis therapy in SNUH. Patients with im-
pending ESRF who accepted PD as their primary modality were 
subjected to Tenckhoff catheter insertion, usually followed by a 
break-in period of two weeks for tunnel healing and step-wise 
training for exchange procedure. They started PD after the break-
in period. Patients who developed uremic symptoms or uremic 
emergency during this period were temporarily given hemodi-
alysis therapy until the start of PD. A total of 593 patients com-
menced PD at SNUH from January, 2000 until July, 2010. Among 
them, we excluded patients who had previously received hemo-
dialysis for  > 1 month or started dialysis because of a failing re-
nal allograft. Patients were also excluded if they died or switched 
to hemodialysis within 3 months after starting PD or discontin-
ued PD due to recovering renal function. Excluded patients were 
not significantly different from the included patients with respect 
to age, sex ratio, body mass index (BMI), and comorbidity. Final-
ly, 491 PD patients were selected and retrospectively analyzed 
in the present study. Demographic, clinical and outcomes data 
were retrieved from the PD registry data in SNUH PD Center. 
These data included age, sex, underlying renal disease, labora-
tory test results, comorbidity, vintage, and physician in charge. 
Laboratory tests such as highly sensitivie C-reactive protein 
(hsCRP), hemoglobin (Hb), albumin at the time of commenc-
ing PD were employed for analysis. Degree of comorbidity was 
assessed based on the Davies comorbidity score, which compris-
es seven comorbid conditions, leading to three risk groups, i.e., 
low (no comorbid disease), intermediate (1 or 2 comorbid dis-
eases) and high (3 or more comorbid diseases) risk groups (19). 
 
GFR measurements before dialysis
Patients with eGFR  < 30 mL/min/1.73 m
2 are regularly followed 
by a nephrologist at 4- to 6-week interval. For them, eGFR was 
estimated by abbreviated Modification of Diet in Renal Disease 
(MDRD) equation. PD patients were divided into ‘early starters 
(n = 244)’ and ‘late starters (n = 247)’ on the basis of the eGFR 
measured within 6 weeks before start of dialysis, using median 
value of 7.7 mL/min/1.73 m
2.
PD protocol 
The choice of particular PD system such as brand and manual 
vs automated PD was left to the discretion of the patients. Dial-
ysis regimens, i.e., the number of exchanges and choice of PD 
solutions were adjusted by nephrologists to meet the Kt/V target 
of  > 1.7 and achieve euvolemic status. Patients were regularly 
monitored for dialysis adequacy, peritoneal solute transport 
rate, peritonitis, and exit site infection. 
Outcome endpoints 
All-cause mortality was the primary outcome of the present 
study. Data regarding conversion to hemodialysis therapy, kid-
ney transplantation, transfer to another center, and loss to fol-
low-up were censored in the all-cause mortality analysis. Deaths 
within three months of transfer to hemodialysis were deemed 
to be PD-related mortalities. Technical failure, cardiovascular 
(CV) event, and composite event defined as either CV event or 
patient death were analyzed, as well. Technical failure was de-
fined as transfer to hemodialysis therapy because of peritonitis, 
ultrafiltration failure, inadequate dialysis, exit-site and/or tunnel 
infection, and mechanical problems. CV event was defined as 
new development of myocardial infarction, angina, fatal or non-
fatal stroke, or peripheral vascular disease. Coronary angioplas-
ty, coronary artery bypass graft, carotid endarterectomy, or pe-
ripheral revascularization procedure were also included in the 
definition of CV event. 
Statistical analysis
SPSS version 16.0 for Windows (SPSS Inc., Chicago, IL, USA) was 
used for the statistical analysis. Normality of data distribution 
was tested using the Kolmogorov-Smirnov test. Variables with-
out a normal distribution were either transformed into logarith-
mic scale and subjected to parametric tests or analyzed by non-
parametric test. Values with normal distribution are expressed Oh K-H, et al.  •  Initiation Timing of PD and Outcomes
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as mean standard deviation, while those without normal distri-
bution were shown as median and interquartile range. For con-
tinuous variables, comparison between two groups was made 
by using Student t test or Mann Whitney U test. Chi square test 
or Fisher’s exact test was used for categorical variables. 
  The early starter group differed markedly from late starter 
group with respect to the observed pre-dialysis covariates. There-
fore, we decided to account for such differences between early 
and late starter groups by developing a PS for being an early start-
er group. PS analysis is a post hoc statistical method that esti-
mates the impact of a treatment when subjects are not random-
ly assigned to a specific treatment group. It supports to simulta-
neously control all the known patient factors that might be re-
lated with the time of PD commencement. Logistic regression 
was performed to calculate the risk, or the propensity of each 
patient to be included in the early starter group. Hosmer-Leme-
show’s test was performed to evaluate the goodness-of-fit of our 
model. The calculated PS was either used for one-to-one match-
ing in estimating the benefit of early initiation of PD in multivar-
iate analysis or for stratified analysis of the outcome by the quar-
tiles of the PS. Comparisons between PS matched pairs were 
performed by using paired t-test for continuous variables and 
McNemar test for categorical variables.
  Kaplan-Meier analysis was employed to determine all-cause 
mortality, technical failure, and CV event free survival. In an anal-
ysis for the hazard ratio (HR) for the primary and secondary out-
comes, the models were checked for proportionality assump-
tions. Then, a multivariate Cox proportional hazards model with 
the aid of forward selection was used to adjust the covariates 
for the effect of early dialysis initiation and to estimate the HR 
and associated 95% confidence interval (CI), since the assump-
tions of a constant HR over time were met. At all the statistical 
analysis, P < 0.05 was considered statistically significant. 
Ethics statement
The study protocol was approved by the institutional review 
board of SNUH (IRB No. H-1010-037-335). Informed consent 
was waived by the board.
RESULTS
The study population was incident PD patients who underwent 
Tenckhoff catheter insertion and subsequently started PD at 
SNUH from January 2000 to July 2010. Among 593 patients who 
commenced PD during that period, 491 PD patients were select-
ed and analyzed by calculating the PS to be in the early starter 
group in the present study. 
  For the overall population, the median length of follow-up 
was 25 months, 5-yr patient survival rate was 84.3%, and 5-yr 
technique survival was 74.5%. The study population was classi-
fied into early and late starter groups on the basis of median GFR 
(7.7 mL/min/1.73 m
2) at the time of commencing PD. The base-
line characteristics of the two groups are detailed in the Table 1. 
Estimated GFR for early and late starter groups were 10.8 ± 2.5 
Table 1. Baseline characteristics of the study subjects
Parameters
Overall series Propensity-score-matched pairs
Early starter 
(n = 244) 
Late starter 
(n = 247)
P
Early starter 
(n = 136)
Late starter 
(n = 136)
P
Age (yr)   51.0 ± 14.5   46.4 ± 13.6 < 0.001   48.4 ± 14.5   48.0 ± 12.8 0.80
Sex (male/female) 163/81 131/116 0.002 83/53 82/54 1.0
BMI (kg/m
2) 22.1 ± 3.1 22.4 ± 3.3 0.314 22.3 ± 3.2 22.2 ± 3.3 0.75
eGFR (mL/min/1.73 m
2) 10.8 ± 2.5   5.5 ± 1.3 < 0.001 10.4 ± 2.2   5.8 ± 1.2 < 0.001
Davies Comorbidity score (No., %)
   Low (0)
   Intermediate (1-2)
   High (3-7)
 
  92 (37.7%)
123 (50.4%)
  29 (11.9%)
 
151 (61.1%)
  88 (35.6%)
  8 (3.2%)
< 0.001  
   66 (48.5%)
   64 (47.1%)
   6 (4.4%)
 
  70 (51.5%)
  61 (44.9%)
  5 (3.7%)
0.84
hsCRP (mg/dL)   1.0 ± 2.1   0.7 ± 1.4 0.10   1.1 ± 2.5   0.9 ± 1.7 0.44
Albumin (g/dL)   3.54 ± 0.52   3.62 ± 0.67 0.11   3.52 ± 0.51   3.63 ± 0.63 0.15
Hemoglobin (g/dL) 10.0 ± 1.4   9.5 ± 1.3 < 0.001   9.7 ± 1.3   9.6 ± 1.2 0.34
Diabetes (No., %) 108 (44.3%)   60 (24.3%) < 0.001    50 (36.8%)   42 (30.9%) 0.34
Heart failure (No., %)   44 (18.0%) 19 (7.7%) < 0.001  12 (8.8%)   14 (10.3%) 0.83
Malignancy (No., %)   3 (1.2%)   3 (1.2%) 1.0 0 (0%)   1 (0.7%) 1.0
Ischemic heart disease (No., %)   54 (22.1%) 20 (8.1%) < 0.001    18 (13.2%)   15 (11.0%) 0.69
Peripheral artery disease (No., %)   33 (13.5%) 14 (5.7%) 0.003  10 (7.4%) 13 (9.6%) 0.68
Connective tissue disease (No., %)   6 (2.5%)   6 (2.4%) 1.0    4 (2.9%)   2 (1.5%) 0.69
Education years (No., %)
   < 6 yr (0)
   6-9 yr (1-2)
   9-12 yr (3-7)
   12-16 yr
   > 16 yr
 
19 (7.9%)
  25 (10.3%)
  84 (34.7%)
110 (45.5%)
  4 (1.7%)
 
14 (5.8%)
22 (9.1%)
  90 (37.2%)
114 (47.1%)
  2 (0.8%)
0.75
 12 (8.9%)
   9 (6.7%)
   50 (37.0%)
   61 (45.2%)
   3 (2.2%)
 
 7 (5.3%)
13 (9.8%)
  52 (39.4%)
  59 (44.7%)
  1 (0.8%)
0.54
BMI, body mass index; eGFR, estimated glomerular filtration rate; hsCRP, highly sensitive C-reactive protein.Oh K-H, et al.  •  Initiation Timing of PD and Outcomes
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and 5.5 ± 1.3 mL/min/1.73 m
2, respectively (P < 0.001). Early 
starters exhibited older age, male preponderance, higher comor-
bidity scores including diabetes, congestive heart failure, isch-
emic heart disease, peripheral artery diseases, compared to the 
late starter group.
Propensity score analysis 
The variables included in the logistic regression model for the 
calculation of the PS were age, sex, BMI, albumin, hsCRP, diabe-
tes, congestive heart failure, malignancy, ischemic heart disease, 
peripheral vascular disease, connective tissue disease, school 
education years, commencing year, and physician (Hosmer-
Lemeshow’s test, P = 0.6311). 
  One-to-one propensity matching between the two groups 
was performed according to the PS. The baseline characteristics 
of the PS-matched pairs (n = 136) is described in the Table 1. No 
difference was observed with respect to the age, gender ratio, 
BMI, Hb, albumin, hsCRP, comorbidty parameters and educa-
tion years.
  Post hoc analysis was performed by defining quartiles of the 
PS and estimating the outcomes in each quartile by Kaplan-Meier 
method. Here, we selected to employ stratification in quartiles, 
instead of quintiles, because of the limited size of our patient 
population.
Outcomes of early vs late dialysis in the PS-matched pairs 
One-to-one PS matching provided 136 pairs of patients who un-
derwent early or late initiation of PD (Table 1). During the me-
Table 2. Causes of death in each group
Diseases Early starter (n = 136) Late starter (n = 136)
Cardiovascular death including 
   cerebrovascular event
  4   3
Peritonitis   0   0
Infection, sepsis other than 
   peritonitis
  1   3
Malignancy   0   0
Uremia   0   0
Others   2   0
Indeterminate   7   4
Total 14 10
Fig. 1. Primary and secondary outcomes of early and late starters of peritoneal dialysis adjusted by start age, sex, body mass index, albumin, hemoglobin, hsCRP, diabetes, 
congestive heart failure, malignancy, peripheral artery disease, ischemic heart disease, collagen disorder, and education level. (A) All-cause mortality (P = 0.17). (B) Technique 
failure (P = 0.62). (C) Cardiovascular event (P = 0.96). (D) Composite event (P = 0.86) free survival. 
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dian follow-up of 27 months, 14 of 136 patients in early starter 
group and 10 of 136 patients in the late starter group died (Table 
2 and 3, adjusted hazard ratio with early initiation 0.47, 95% con-
fidence interval [CI] 0.16 to 1.35, P = 0.17). As shown in the Fig. 1, 
no significant differences were observed in terms of all-cause 
mortality (P = 0.17), technique failure (P = 0.62), CV event (P =  
0.96) and composite event (P = 0.86) between the early and late 
starters.
Stratification analysis in the PS quartiles 
Stratification analysis in the PS quartiles (n = 491, Table 4) showed 
no trend toward better or poorer survival in terms of all-cause 
mortality. 
 
DISCUSSION
The present study showed that the all cause of mortality, tech-
nical failure, CV event, and composite event were not different 
between early and late starters of peritoneal dialysis therapy 
when we estimated outcomes with PS matched pairs model. In 
a stratification analysis by the PS quartiles, all-cause mortality 
was not different across the quartiles of PS. 
  It had been suggested that early initiation of dialysis might 
improve nutrition and quality of life. It had also been suggested 
that patients initiated dialysis early had less uremic complica-
tion with consequent decrease in hospitalization, mortality, and 
cost (20, 21). The evidence for these was that lower GFR at the 
initiation of dialysis was associated with lower serum albumin 
level, which, in turn, correlated with higher mortality (22). There-
fore, it had been suggested that early initiation of dialysis will 
prevent malnutrition and thereby decrease mortality. Several 
observational cohort and case-control studies so far also showed 
that early initiation of dialysis was associated with improved sur-
vival rate (23, 24). However, these studies did not account for 
lead-time bias or comorbidities.
  In contrast, other observational studies and a recent random-
ized controlled trial have suggested that initiation of dialysis at 
higher eGFR had no effect on survival or worsened survival rate 
(5-12, 25, 26). However, serum Cr depends not only on the RRF 
but also on the muscle mass. Lower serum Cr at dialysis com-
mencement might indicate both better RRF and poorer nutri-
tion with lower muscle mass. Such lower muscle mass could 
partly account for the apparent association between start eGFR 
and subsequent mortality risk (27). 
  The recently published randomized controlled trial, the IDEAL 
study, found no survival benefit of early dialysis initiation (11). 
This study randomly allocated the 828 ESRF patients of Austra-
lia and New Zealand to early or late starter groups and followed 
them up for 3.59 yr. However, the mean eGFR difference between 
two groups of IDEAL study was only 1.8 mL/min/1.73 m
2 (early 
starters; 9.0 mL/min/1.73 m
2 vs late starters; 7.2 mL/min/1.73 
m
2). Besides, the study participants comprised similar propor-
tions of hemodialysis and PD patients and did not address the 
effect of start eGFR on the survival with respect to the PD alone. 
RRF is better preserved with PD than hemodialysis (14, 15) and 
the RRF is an important prognostic factor in ESRF patients (16, 
17). Therefore, results from the IDEAL study could not be di-
rectly translated into PD.
  In our retrospective analysis for the effect of early vs late PD 
commencement on the various outcomes, we employed two 
types of models using PS in order to eliminate the bias due to 
comorbidities. In a retrospective study, initiation of dialysis de-
pends more heavily on the grade of comorbidity rather than 
eGFR, since uremic symptom is more closely associated with 
the comorbidity than eGFR. In the present study, factors that 
generally lead to a poor prognosis, such as old age, lower albu-
min, higher hsCRP, diabetes, congestive heart failure, ischemic 
heart disease, and peripheral vascular disease, were more com-
mon in early starters than in late starters before matching. There-
fore, by employing PS matching method, we tried to eliminate 
the possible effect of comorbid conditions. After matching, all 
the pre-dialysis covariates became similar between the two groups, 
only except eGFR at dialysis initiation (10.4 2.2 vs 5.8 1.2 mL/
min/1.73 m
2, P < 0.001). In contrast to the IDEAL study, the 
present study exhibited a remarkable difference of eGFR be-
tween the two groups.
  The present study showed 14 out of 136 from early starter group 
and 10 out of 136 late starter group died from any cause during 
Table 4. Hazard ratio of all-cause mortality by quartiles of propensity score
PS Adjusted HR (95% CI) P
Overall  1.37 (0.69-2.71) 0.36
PS_Q1 4.26 (0.60-30.4) 0.15
PS_Q2 0.65 (0.13-3.39) 0.62
PS_Q3 2.50 (0.71-8.83) 0.15
PS_Q4 1.28 (0.43-3.79) 0.66
PS_Q1,Q2,Q3,Q4, propensitiy-score quartile groups from first (Q1) to fourth (Q4) quar-
tile; HR adjusted by propensity score and late starter as reference group.
Table 3. Multivariate Cox regression analysis for overall mortality
Variables P
*Adjusted 
HR
95% CI for HR
Lower Upper
Early (vs late) start group 0.17 0.47 0.16   1.35
Hemoglobin (per 1 g/dL) 0.37 0.80 0.49   1.30
Sex (F vs M) 0.61 0.68 0.15   2.97
Start age (per 1 yr) 0.03 1.06 1.01   1.12
BMI (kg/m
2) 0.21 0.84 0.64   1.10
Albumin (g/dL) 0.89 0.91 0.24   3.36
hsCRP (mg/dL) 0.07 1.18 0.98   1.42
Diabetes mellitus 0.11 0.17 0.02   1.47
Congestive heart failure 0.80 1.33 0.14 12.28
*Adjusted for start age, sex, BMI, albumin, Hb, hsCRP, diabetes, congestive heart failure, 
malignancy, peripheral artery disease, ischemic heart disease, collagen disorder, and 
education level. HR, hazard ratio; CI, confidence interval; BMI, body mass index; hsCRP, 
highly sensitive C-reactive protein.Oh K-H, et al.  •  Initiation Timing of PD and Outcomes
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median 27-months follow-up. This indicates a lower mortality 
rate, compared with other reports from the Caucacians (28). Bet-
ter clinical outcomes of Asian PD patients, as compared to the 
western PD population, are also reported elsewhere (29, 30). 
  The present study has several potential limitations. First, al-
though as many pre-dialysis covariates as available were includ-
ed in the PS calculation, other determinants might remain un-
recognized in this retrospective study. Second, MDRD equation 
was used to calculate eGFR at initiation timing of PD. As men-
tioned above, lower serum Cr could be a feature of both a better 
RRF and a poorer nutritional status. Although our PS calcula-
tion included the albumin level, detailed information for other 
nutritional parameters was absent. Lastly, lead time bias might 
have an influence at early stages of follow-up period and this 
effect might disappear at later stages.
  In conclusion, early commencement of PD does not reduce 
the mortality risk and other outcomes in our study. Although 
the recent guidelines suggest that initiation of dialysis at higher 
eGFR, physicians should not determine the time to initiate PD 
therapy simply rely on the eGFR alone. PD may be delayed un-
til traditional clinical indications for dialysis are present. 
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